Article Text

Download PDFPDF

Epidemiology and partner notification
P41 Women's health study of Mycoplasma genitalium: a feasibility study
  1. S Dave1,
  2. S R Kerry2,
  3. P Oakeshott2,
  4. F McGregor3,
  5. E Cannon3,
  6. J M Stephenson1
  1. 1University College London, London, UK
  2. 2St. George's University of London, London, UK
  3. 3CNWL Camden Provider Services, London, UK


Background The role of Mycoplasma genitalium (∼3% prevalence in women) in PID is unclear. An opportunity exists to study its natural history since there are no UK treatment guidelines. We conducted a feasibility study.

Objectives In women attending GUM clinics to determine: (1) recruitment and follow-up rates after 3 and 6 months, (2) feasibility of obtaining NHS numbers, (3) facilitators and barriers to follow-up.

Methods Women aged 16–24 years recruited from two GUM clinics completed a questionnaire and provided two self-taken vaginal samples. One sample was tested for chlamydia. We are testing for M genitalium and conducting 3-month follow-up.

Results Recruitment rate was 67% (199/296). Non-responders were similar in age to responders (20.6 SD 2.5 vs 20.7 SD 2.5 years) but more likely to come from ethnic minority groups: 56% (37/66) vs 36% (71/195), p<0.05. Among responders, mean sexual debut age was 16.3 years (range 12–23 n=198); 59% (116/195) reported ≥2 sexual partners and 17% (31/186) consistently used condoms in the preceding 12 months. 8.2% (16/197) had chlamydia and 0.5% (1/197) gonorrhoea on testing. At recruitment 196 participants consented to NHS numbers being obtained and used to access medical records; 197 participants agreed to 3-month follow-up. We have been able to contact ∼50% of participants for follow-up.

Discussion Most women consented to NHS number and medical record access. This is important for investigating long-term sequelae of STIs. Fewer women took part in follow-up than agreed at recruitment. It is important to understand the reasons for this.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.